ESSAY: Nipah, Shigella, Mpox — Why Kerala Is the World's Epicenter of Emerging Zoonoses

ESSAY: Nipah, Shigella, Mpox — Why Kerala Is the World's Epicenter of Emerging Zoonoses

Introduction: An Indian State That Concentrates the World's Epidemiological Nightmares

Kerala in June 2026: Two Simultaneous Epidemics, One Shared Vulnerability

In June 2026, Kerala — one of India's most educated, best-served medically and most prosperous states — found itself simultaneously grappling with two distinct epidemics of entirely different natures. On one side, the Nipah virus: a single confirmed case in Kozhikode, a 43-year-old man on a ventilator in an intensive care unit, 104 contacts under active surveillance. On the other, an outbreak of Shigella — a bacterial infection transmitted through water and food — which had caused six deaths and 140 cases in June alone, bringing the annual total to 216 confirmed cases according to data from June 20, 2026.

This coexistence is not an accident. It reveals a unique ecological, health and social configuration that has made Kerala the world's primary hotspot for emerging zoonoses since 2018. Understanding why this state concentrates these successive outbreaks is not an academic exercise: it is a matter of survival for humanity, in the most literal sense of the term. The next global pandemic could very well start here.

The Nipah Virus: A Killer With an Exceptional Mortality Rate

The Nipah virus (NiV) is not an ordinary pathogen. Its mortality rate ranges between 40% and 75% depending on the outbreak, making it one of the most lethal infectious agents known today. There is no licensed vaccine, no specific treatment — only intensive supportive care. The World Health Organization (WHO) classifies it among priority pathogens for accelerated medical countermeasure development, alongside Ebola, Disease X and other agents with high pandemic potential.

The case confirmed in Kozhikode on June 11, 2026 by the National Institute of Virology in Pune follows a pattern that has now become familiar for Kerala: since 2018, the state has experienced outbreaks in 2019, 2021, 2023, 2025 and again in 2026. This recurrence is itself a major epidemiological signal that should alert the international community.

Kerala as an Open-Air Laboratory for Zoonotic Spillovers

Fruit Bats: Natural Hosts and Viral Carriers

Fruit bats of the genus Pteropus, commonly known as flying foxes, are the natural hosts of the Nipah virus. They carry the virus without falling ill themselves — a classic phenomenon of co-evolutionary adaptation — and transmit it to humans via their secretions (saliva, urine, droppings) that contaminate fruit, water sources or freshly harvested date palm sap, particularly consumed in Bangladesh and South India.

Kerala is geographically and ecologically ideal for flying foxes: dense forests in the Western Ghats, an abundance of fruit trees (mango, jackfruit, palm), and buffer zones between forest and human habitat eroded by development. In the current case, the patient from Kozhikode is a merchant whose warehouse, located near dense vegetation, houses a colony of fruit bats. The spillover pattern is the same as in 2018, 2023 and 2025: partial deforestation, involuntary cohabitation with the hosts, direct transmission.

Deforestation and Urbanization as Drivers of Zoonotic Risk

The repeated emergence of Nipah in Kerala is not independent of environmental change. The Western Ghats, classified among the world's biodiversity hotspots, face increasing pressure from agriculture, urbanization and tourism. Every hectare of cleared forest creates new contacts between wildlife and human populations, mechanically increasing the risk of viral spillover.

A study published in the New Indian Express on June 12, 2026, citing ecological changes in the districts of Kozhikode and Malappuram, identifies the disruption of natural habitats as an aggravating factor in the repeated outbreaks. Deforestation is not a direct cause of each individual case, but it constitutes the structural framework within which these emergences occur with increasing frequency. This is a lesson the international community struggles to absorb.

Shigella in Kerala: When an Ancient Bacterium Strikes a Modern State

140 Cases, Six Deaths in June: A Damning Toll for a Developed State

Shigella is an intestinal bacterium known since the 19th century, responsible for bacillary dysentery. It spreads through contaminated water and food, as well as by direct contact with infected individuals. It should, in theory, be easy to control in a state with a developed drinking water network and a reputed public health system like Kerala's. Yet in June 2026, the toll is severe: 140 cases and six deaths for June alone, including several children, bringing the annual total to 216 cases with six fatalities.

The most affected districts — Kozhikode (42 cases in June), Malappuram (20 cases), Wayanad — are also those that concentrate rural populations, unchlorinated water sources and variable food hygiene practices. The school outbreak in Wayanad, where hundreds of students were affected after drinking water from a contaminated well, illustrates the persistent fragility of infrastructure even in a generally well-equipped state.

Nipah-Shigella Coexistence: A Public Health System Under Double Pressure

Managing simultaneously a Nipah outbreak — which requires considerable resources for contact tracing, isolation and healthcare worker protection — and a Shigella outbreak in the same districts represents a formidable logistical and human challenge for the Kerala Department of Health. Medical teams are mobilized on two fronts, with different protocols, different risks and overlapping target populations.

Kerala's Health Ministry has established a high-level committee specifically dedicated to studying recurring seasonal epidemics in the state. This committee includes experts from the WHO, government and private clinicians, One Health specialists (the approach integrating human, animal and environmental health), and representatives from the livestock and food safety departments. It is an appropriate institutional response. But it comes after years of repeated warnings.

No Nipah Vaccine: The Urgency of a Global Race Against Time

Why Do We Still Not Have a Nipah Vaccine?

The question is legitimate and honesty demands it be addressed without evasion. The Nipah virus has been known since 1998. Its pandemic potential has been documented since at least 2004. The WHO identified it as a priority in its R&D Blueprint. Vaccine candidates — including mRNA vaccines developed in the wake of the COVID-19 pandemic — exist in early stages of clinical development. And yet, in June 2026, when a 43-year-old man is placed on a ventilator in Kozhikode, medical teams have only supportive care to offer him.

The answer lies in market logic: Nipah kills relatively few people (a few dozen to a few hundred per outbreak), in low-income geographies, with insufficient frequency to justify the billions required for accelerated development under conventional pharmaceutical logic. This is precisely the problem that CEPI (the Coalition for Epidemic Preparedness Innovations) has been trying to solve since its creation, but with resources that remain inadequate.

The Catastrophe Scenario: A Mutation Toward Airborne Transmission

Nipah currently spreads through direct contact with the biological fluids of an infected person — a transmission mode that naturally limits its spread. But the virus has a biologically troubling peculiarity: it belongs to the Paramyxoviridae family, which includes pathogens capable of airborne transmission. Modeling studies have estimated that if Nipah acquired airborne transmission comparable to a coronavirus, its fatality rate (40–75%) combined with that transmission mode could make it potentially the deadliest pathogen in modern history.

This scenario is not inevitable — transmissibility mutations are probabilistic, not deterministic events. But every Nipah outbreak in a hospital setting represents an opportunity for the virus to adapt to human-to-human transmission in a dense environment. The 1998–1999 Malaysian outbreak, which caused 265 infections and 105 deaths, had already demonstrated the virus's ability to affect family and hospital clusters. Every new case is an epidemiological roll of the dice.

Kerala's Response: A Global Model of Reactive Epidemiology

Contact Tracing, Community Surveillance, One Health: The Kerala Method

Kerala's response to every Nipah outbreak is unanimously praised by international experts as a model of epidemic management. In June 2026, authorities identified and placed under surveillance the 104 contacts of the index case within 48 hours, with twice-daily telephone monitoring from a central coordination room. Field investigations covered the 320 households (1,047 residents) of the Ramanattukara ward — the source of the case — within just a few days.

Environmental samples — bats, droppings, animal specimens within a 5 km radius of the outbreak — were sent to the National Institute of High Security Animal Diseases (NIHSAD) in Bhopal. Psychosocial support was deployed for the 125 people in quarantine. This responsiveness, which would have taken weeks to organize in most countries, explains why Kerala has never triggered sustained community transmission of Nipah.

The Model's Limits: Kerala Cannot Carry This Alone

While Kerala's immediate response is exemplary, its structural prevention capacity is constrained by factors that exceed its own competencies. Combating deforestation in the Western Ghats involves neighboring state governments, the Indian federal government and powerful economic actors. Developing vaccines and treatments against Nipah depends on international funding and a global political will that is slow to materialize.

Moreover, Kerala is not an island: its international airports (Kozhikode, Kochi, Thiruvananthapuram) receive millions of travelers per year, connecting the state to the Persian Gulf, Southeast Asia, Europe and North America. Should Nipah acquire greater transmissibility, Kerala's airports could become within hours vectors of global dispersal. The enhanced border screening measures that Taiwan, Thailand and other countries have begun implementing reflect a growing awareness of this risk.

The Global Dimension: Kerala as a Signal for International Health Governance

The WHO and Priority Pathogens: The Urgency of Increased Funding

The WHO has placed Nipah in its R&D Blueprint — a list of pathogens for which accelerated development of countermeasures is considered urgent. But funding for CEPI, the international body dedicated to this development, remains far short of the identified needs. Between 2017 and 2026, tens of millions of dollars have been mobilized for Nipah research — a tiny fraction of the trillions of dollars the COVID-19 pandemic cost the global economy.

The logic is perverse but understandable: governments invest massively in pandemic preparedness after crises, not before. COVID-19 generated unprecedented investment in mRNA technologies, which could theoretically be applied rapidly to Nipah. Research consortia such as Moderna and IAVI have candidate vaccines in development. But the pace of this development depends on sustained funding that post-COVID austerity policies are putting at risk.

One Health: The Only Systemic Response to the Zoonosis Crisis

The One Health approach — which recognizes that human, animal and environmental health are inseparable — is officially endorsed by the WHO, the FAO and the OIE. In practice, its integration into national health policies remains superficial. Kerala is one of the few states in the world to have established an operational One Health committee for its Nipah outbreaks, bringing together veterinarians, ecologists and food safety experts.

For this approach to truly change the picture, it must apply not only in response to outbreaks — as is currently the case — but in permanent prevention: monitoring of flying fox populations, tracking of forest-agriculture interfaces, restriction of human activities in zones of high viral reservoir density. This requires continuous investment, political will, and cooperation between ministries that are unaccustomed to working together.

Unlearned Lessons From COVID: Are We Better Prepared?

Post-COVID: Investments That Followed and Those That Did Not

The COVID-19 pandemic generated substantial political promises: strengthened surveillance systems, accelerated development of platform vaccines, strategic stockpiles, improved international coordination mechanisms. Five years after the pandemic began, the record is mixed. mRNA technology has made spectacular advances. Epidemiological surveillance systems have improved in many countries. The WHO Pandemic Treaty, after years of difficult negotiation, was ultimately adopted, although with compromises that limit its scope.

The question of sustainable funding for pre-pandemic preparedness — true prevention — however, remains unresolved. Governments have cut public health budgets under post-COVID deficit pressures. Epidemiological surveillance positions have been eliminated. Pandemic fatigue has generated political resistance to preventive investments that appear abstract in the absence of a visible crisis. This is the window of vulnerability in which the Nipah outbreak in Kerala is unfolding in June 2026.

Emerging Variants and the Cumulative Effect of Repeated Outbreaks

Every Nipah outbreak in Kerala statistically increases the probability of an advantageous mutation for the virus. Natural selection has no agenda, but it works mechanically: in an environment where human-to-human contacts with the Nipah virus occur regularly, the most transmissible variants will have a selective advantage. This process is slow, probabilistic and not inevitable — but it is real.

Comparative virology of Bangladesh Nipah (clades) and Kerala Nipah already shows significant genetic differences that complicate the development of universal vaccines. The genetic diversity of circulating strains, fed by recurring outbreaks, is itself a risk factor for the effectiveness of future countermeasures.

Environmental Surveillance: Mapping Spillover Risk Zones

Serosurveys on Animal Populations: The Essential Work We Are Not Doing Enough Of

The early detection of future zoonotic epidemics requires systematic surveillance of animal reservoir populations before the virus crosses the species barrier. Serological surveillance programs on flying fox populations in the Western Ghats have been implemented since the 2018 outbreak, making it possible to identify zones of high Nipah virus prevalence among animals. These data are invaluable for anticipating the geographic areas where the risk of spillover is highest.

However, these surveillance programs suffer from a lack of continuity and resources. The National Institute of Virology in Pune and its academic partners in Kerala operate with limited budgets that do not allow for the frequency and geographic breadth of monitoring that the identified risks would justify. Animal surveillance costs less than an epidemic response — but it is politically less visible and therefore chronically underfunded.

Mapping Forest-Agriculture Interfaces: Identifying Hotspots Before Outbreaks

Research published in the New Indian Express on June 12, 2026, citing studies on ecological changes in the districts of Kozhikode and Malappuram, identified specific forest-agriculture interfaces where the density of flying foxes and human presence overlap in particularly risky ways. These zones — vegetable gardens adjacent to forest fragments, warehouses near dense vegetation, fruit farms at the edge of the Ghats — are where spillovers occur most frequently.

Precise mapping of these hotspots, combined with targeted preventive measures — enhanced surveillance of human populations living nearby, information on risky practices, physical protection of food stocks — could significantly reduce the frequency of index cases. This is a relatively inexpensive preventive public health intervention that is not yet systematically deployed at the required scale in Kerala or in other Indian states facing comparable risk.

Conclusion: Kerala as Mirror and as Warning

A State That Must Bear the Weight of Global Neglect Alone

Kerala has developed, by necessity, an expertise in managing Nipah outbreaks that is unique in the world. Its medical teams, its tracing protocols, its public communication are models that the WHO recommends to other countries. But this expertise has been built through repeated crises, painful learning and human loss. It should not be the only bulwark against a pathogen with global pandemic potential.

The simultaneous outbreak of Nipah and Shigella in June 2026 is a reminder that public health systems, even excellent ones, have limits when facing multiple simultaneous crises in a resource-constrained context. Shigella — a bacterial infection that can be prevented with clean drinking water and good hygiene practices — is a reminder that "old" diseases have not disappeared and that infrastructure inequalities persist even in the most developed states of an emerging country.

The Call to Action: Vaccine, One Health, Global Surveillance

Three priorities emerge with an urgency made all the more pressing by the events of June 2026. First, accelerated funding for a Nipah vaccine through CEPI, with political mobilization at the G20 level comparable to that which the COVID-19 pandemic eventually triggered. Second, operational integration of the One Health approach into environmental policies for high-density flying fox regions in South India, with strengthened legal protections for the forests of the Western Ghats. Third, the strengthening of global epidemiological surveillance capacities, with resources so that at-risk countries can share their data in real time with international institutions.

Kerala is doing its part. The question is whether the rest of the world will do its own before the next outbreak is the wrong one at the wrong moment.

By Maxime Marquette, columnist

Columnist's transparency note

Position and Method

Maxime Marquette is a generalist columnist with a specialization in international crises. He is neither a virologist nor an epidemiologist. This essay is based on public sources: the WHO report of June 25, 2026 on the Nipah outbreak in Kerala, Indian press reports (India Today, The Hindu, Republic World, Omnicuris), and epidemiological analyses available in the open scientific literature. No expert was contacted directly for this essay.

Projections on the pandemic risk of Nipah are based on published modeling and official assessments from the WHO and CEPI. They represent possible scenarios, not certainties. The distinction between factual and speculative risk has been maintained as clearly as possible throughout.

Stated Biases

The columnist is convinced that pandemic preparedness is underfunded relative to known risks. This position is shared by many global health experts but remains politically contested. The essay does not claim neutrality on this question — it advocates for increased preventive investment, a position that may be legitimately challenged on political and economic grounds.

The explicit limits of this essay include the inability to access raw epidemiological data from Kerala, the preliminary results of genomic analyses of the 2026 Nipah strain, and the internal deliberations of vaccine research institutions. For these matters, uncertainty is explicitly acknowledged.

Sources

Primary sources

WHO — Disease Outbreak News: Nipah virus disease in India — June 25, 2026

India Today — Shigella outbreak worsens in Kerala, 133 cases — June 20, 2026

The Hindu — One more Shigella death, seven fresh cases reported in Kerala — June 21, 2026

Secondary sources

New Indian Express — Recurring Nipah outbreaks in Kerala linked to ecological changes — June 12, 2026

Omnicuris — Shigella outbreak in Kerala worsens — June 24, 2026

Mathrubhumi English — Nipah alert in Kozhikode, Kerala — June 12, 2026

The Print — 146 cases, five deaths due to Shigella in Kerala since January 2026 — June 16, 2026